EU Regulation 2024/1689 on Artificial Intelligence has the aim to introduce strict rules for the design, implementation and placing on the market of Artificial Intelligence systems, to be applied both to suppliers established in European territory and to suppliers established outside the European Union.
The impact of said Regulation on so-called SAMD (i.e., software as medical device) classified as “high risk” seems to materialize as significant. In this regard, it is worth noting […]
European Union: The impact of AI Act (EU Regulation 2024/1689) on legacy and in-house …
NewsChest Technology site
